The impact of COVID-19 on the management of medicines at a public health centre: A showcase of pharmacist resilience
DOI:
https://doi.org/10.46542/pe.2023.232.223226Keywords:
COVID-19, Pharmacy practice, Pharmacist, Health systemAbstract
Background: The COVID-19 pandemic has had an impact on the management of medicines at public health centres in Indonesia. Travel restrictions and shortages of certain medicines have put pharmacists in difficult situations and made ensuring the uninterrupted supply of medicines to patients more challenging.
Objective: This study aims to identify the impact of COVID-19 on the management of medicines at Indonesian public health centres, and highlight the pharmacist’s resilience in community practice.
Method: Four focus group discussions (FGDs) were conducted in May 2021 involving 40 pharmacists at public health centres in Surabaya, Indonesia. Each group was asked about the professional practice of pharmacists during the 2020 and 2021 pandemic, including the obstacles and strategies for maintaining practice. The FGDs were audio-recorded, transcribed verbatim, and analysed thematically.
Result: The participants agreed that the COVID-19 pandemic presented a significant challenge in the planning and use of medicines, and pushed pharmacist to change their procurement methods. Travel restrictions has resulted in a significant drop in patient visits. The situation have caused several drugs, particularly antibiotics, to go unused and expire, whilst there was an increased demand for COVID-19 medicines. Pharmacists were eventually able to cope with the problems by developing adaptability skills and by collaborating with others.
Conclusion: COVID-19 presented a series of challenges in the management of medicines at public health centres in Indonesia. Pharmacists have a strategic role in overcoming these challenges, this study highlights resilience as key for successful pharmacy practice.
References
Al Meslamani, A.Z., Aldulaymi, R., El Sharu, H., Alwarawrah, Z., Ibrahim, O.M., & Al Mazrouei, N. (2022). The patterns and determinants of telemedicine use during the COVID-19 crisis: A nationwide study. Journal of the American Pharmacists Association, 62(6), 1778–1785. https://doi.org/10.1016/j.japh.2022.05.020
Baum, A., Kaboli, P.J., & Schwartz, M.D. (2021). Reduced In-Person and Increased Telehealth Outpatient Visits During the COVID-19 Pandemic. Annals of Internal Medicine, 174(1), 129–131. https://doi.org/10.7326/M20-3026
Billore, S., & Anisimova, T. (2021). Panic buying research: A systematic literature review and future research agenda. International Journal of Consumer Studies, 45(4), 777-804
Cameron, E., & Bushell, M. (2020). Analysis of drug shortages across two countries during pre-pandemic and pandemic times. Research in Social and Administrative Pharmacy, 17. https://doi.org/10.1016/j.sapharm.2020.12.001
Elson, C.E., Oermann, C., Duehlmeyer, S., & Bledsoe, S. (2020). Use of telemedicine to provide clinical pharmacy services during the SARS-CoV-2 pandemic. American Journal of Health-System Pharmacy, 77(13), 1005–1006. https://doi.org/10.1093/ajhp/zxaa112
Djalante, R., Lassa, J., Setiamarga, D., Sudjatma, A., Indrawan, M., Haryanto, B., & Warsilah, H. (2020). Review and analysis of current responses to COVID-19 in Indonesia: Period of January to March 2020. Progress in disaster science, 6, 100091
Elbeddini, A., & Yeats, A. (2020). Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: From direct patient care to telemedicine. Journal of Pharmaceutical Policy and Practice, 13(1), 1–4. https://doi.org/10.1186/s40545-020-00229-z
Ismail, N.E., Hui, W.M., Goh, K.W., Jimam, N. S., Hermansyah, A., & Ming, L.C. (2022). Resilience among Malaysian Community Pharmacists and General Medical Practitioners Using the 10-Item Connor-Davidson Resilience Scale (CD-RISC): The First National Survey. Behavioral Sciences, 12(8), 1–11. https://doi.org/10.3390/bs12080272
Hermansyah, A., Sainsbury, E., & Krass, I. (2018). Multiple policy approaches in improving community pharmacy practice: The case in Indonesia. BMC Health Services Research, 18(1), 1–14. https://doi.org/10.1186/s12913-018-3258-8
Hermansyah, A., Setiawan, C.D., & Riansyah, F. F. (2021). The evident gap between actual and perceived facilities supporting value-added pharmacy services. Pharmacy Education, 21(2), 48–51. https://doi.org/10.46542/pe.2021.212.4851
Hermansyah, A., Wulandari, L., Kristina, S.A., & Meilianti, S. (2020). Primary health care policy and vision for community pharmacy and pharmacists in indonesia. Pharmacy Practice, 18(3), 1–12. https://doi.org/10.18549/PharmPract.2020.3.2085
Hugelius, K., Harada, N., & Marutani, M. (2021). Consequences of visiting restrictions during the COVID‐19 pandemic: An integrative review. International Journal of Nursing Studies, 121, 104000. https://doi.org/10.1016/j.ijnurstu.2021.104000
Johnston, K., O’Reilly, C.L., Cooper, G., & Mitchell, I. (2021). The burden of COVID-19 on pharmacists. Journal of the American Pharmacists Association, 61(2). https://doi.org/10.1016/j.japh.2020.10.013
Malinggas, N., Posangi, J., & Soleman, T. (2015). Analysis of Logistics Management Drugs In Pharmacy Installation District General Hospital Dr. Sam Ratulangi Tondano. JIKMU, 5, No. 2b
Sarasnita, N., Raharjo, U.D., & Rosyad, Y.S. (2021). Dampak Pandemi COVID-19 Terhadap Pelayanan Kesehatan Rumah Sakit di Indonesia. Jurnal Kesehatan, Yogyakarta
Shadiqi, M.A., Hariati, R., Hasan, K.F.A., & Noori’annah Istiqomah, W.A. (2020). Panic buying pada Pandemi Covid-19 : Telaah literatur dari perspektif Psikologi. Universitas Lambung Mangkurat, Banjarbaru
Visacri, M.B., Figueiredo, I.V., & Lima, T.M. (2021). Role of pharmacist during the COVID-19 pandemic: a scoping review. Research in social and administrative pharmacy, 17(1), 1799-1806. https://doi.org/10.1016/j.sapharm.2020.07.003
